Since the heart has no capacity to synthesize carnitine, the homeostasis of the blood carnitine pool is crucial for the heart
Gently pat the remain essence left on your skin Water, Glycerin, Dipropylene Glycol, Propanediol, Hippophae Rhamnoides Water, Caprylic/Capric Triglyceride, PPG-13-Decyltetradeceth-24, Hydroxyacetophenone, Caprylyl Glycol, Carbomer, Tromethamine, Hydrogenated Lecithin, Glutathione(600 ppm), Cetearyl Alcohol, 1,2-Hexanediol, Disodium EDTA, Stearic Acid, Dipotassium Glycyrrhizate, Terminalia Ferdinandiana Fruit Extract, Butylene Glycol, Lecithin, Pentylene Glycol, Acetyl Glutamine, Sodium Hyaluronate, Polyglyceryl-10 Stearate, Panthenol, Folic Acid, Bacillus/Soybean Ferment Extract, Oligopeptide-1, Hexapeptide-11, Oligopeptide-2, Oligopeptide-3, Sodium Ascorbyl Phosphate, Hydrolyzed Pea Protein, Madecassoside, Phytosterols, Squalane, Olea Europaea (Olive) Fruit Oil, Tocopherol, Niacinamide, Hyaluronic Acid, Hydrolyzed Hyaluronic Acid, Hydroxypropyltrimonium Hyaluronate, Hydrolyzed Sodium Hyaluronate, Potassium Hyaluronate, Ceramide NP, Butyrospermum Parkii (Shea) Butter, Ethylhexylglycerin, Biotin, Sodium Hyaluronate Crosspolymer, Pyridoxine, Cyanocobalamin, Riboflavin, Thiamine HCl, Retinol, Bioflavonoids, Sodium Acetylated Hyaluronate, Menadione, Acetyl Hexapeptide-8, Copper Tripeptide-1, Palmitoyl Pentapeptide-4, Linoleic Acid, Beta-Carotene, Fragrance
BAs act in the brain by interacting with key receptors on neurons and glial cells-Farnesoid X receptor (FXR), Takeda G protein receptor 5 (TGR5), GR, and sphingosine-1-phosphate receptor 2 (S1PR2
Developed using Swiss Effervescent Technology, it ensures fast action and absorption, is light on the stomach and is easy to consume as compared to capsules or tablets
Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)NRG-GI004/SWOG-S1610
